Adicet Bio
ACET
81 hedge funds and large institutions have $504M invested in Adicet Bio in 2021 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 31 increasing their positions, 8 reducing their positions, and 8 closing their positions.
400% more funds holding in top 10
Funds holding in top 10: 1 → 5 (+4)
288% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 8
288% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 8
223% more capital invested
Capital invested by funds: $156M → $504M (+$348M)
47% more call options, than puts
Call options by funds: $4.25M | Put options by funds: $2.88M
40% more funds holding
Funds holding: 58 → 81 (+23)
1.06% more ownership
Funds ownership: 3.91% → 4.97% (+1.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
+$32.4M |
| 2 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$16.4M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$8.04M |
| 4 |
FCMV
Foresite Capital Management V
Larkspur,
California
|
+$7.29M |
| 5 |
Two Sigma Investments
New York
|
+$6.72M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$5.05M |
| 2 |
ABG
Ally Bridge Group
New York
|
-$3.33M |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$2.44M |
| 4 |
6CM
683 Capital Management
New York
|
-$2.08M |
| 5 |
Renaissance Technologies
New York
|
-$331K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CA
76
CoreCap Advisors
Southfield,
Michigan
| $1K | +$515 | +3 | New |
|
77
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $1K | +$687 | +4 | New |
|
78
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $190 | +$116K | +678 | New |
|
|
ABG
79
Ally Bridge Group
New York
| – | -$3.33M | -26,563 | Closed |
|
|
NCM
80
Nantahala Capital Management
New Canaan,
Connecticut
| – | -$2.44M | -19,409 | Closed |
|
|
6CM
81
683 Capital Management
New York
| – | -$2.08M | -16,563 | Closed |
|
|
82
Renaissance Technologies
New York
| – | -$331K | -2,639 | Closed |
|
83
Millennium Management
New York
| – | -$178K | -1,422 | Closed |
|
84
SG Americas Securities
New York
| – | -$115K | -916 | Closed |
|
|
PCM
85
Penserra Capital Management
Orinda,
California
| – | -$5K | -46 | Closed |
|
|
TC
86
TAP Consulting
Kirkwood,
Missouri
| – | +$343 | +2 | New |
|
ACET Hedge Fund Activity: Q4 2021 in Review
81 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Adicet Bio (ACET) for Q4 2021, worth a combined $504M — up 223% from $156M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new ACET positions and 8 closed out — a net gain of 23 holders — while 31 added to existing stakes and 8 trimmed.
The largest buyer was RTW Investments, opening a new position worth an estimated $32.4M. The largest seller was Point72 Asset Management, cutting an estimated $5.05M.
- 81 institutional investors held Adicet Bio (ACET) as of Q4 2021, up from 58 in Q3 2021.
- Funds reported $504M of Adicet Bio stock for Q4 2021, up 223% quarter-over-quarter.
- 31 funds opened new Adicet Bio positions in Q4 2021 and 8 closed out, a net change of +23 holders.
- The largest Adicet Bio buyer in Q4 2021 was RTW Investments, an estimated $32.4M added.
- The largest Adicet Bio seller in Q4 2021 was Point72 Asset Management, an estimated $5.05M sold.
Based on aggregated 13F filings for Q4 2021.